Two Sigma Investments, LP Nex Immune, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.2 - $0.3 $2,500 - $3,750	-12,500 Reduced 55.37%	10,077 $2,000
Q2 2023 Aug 14, 2023	SELL	$0.26 - $0.47 $4,178 - $7,553	-16,072 Reduced 41.58%	22,577 $6,000
Q1 2023 May 15, 2023	BUY	$0.3 - $0.6 $11,594 - $23,189	38,649 New	38,649 $14,000
Q1 2022 May 16, 2022	SELL	$1.79 - $4.65 $22,809 - $59,254	-12,743 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.11 - $15.13 $52,373 - $192,801	12,743 New	12,743 $59,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.